Literature DB >> 3082293

Dermatitis herpetiformis. Cutaneous deposition of polyclonal IgA1.

S M Olbricht, T J Flotte, A B Collins, C M Chapman, T J Harrist.   

Abstract

Dermatitis herpetiformis (DH) is a pruritic papulovesicular skin disorder of unknown cause, characterized by granular IgA deposits in the dermis along the dermoepidermal junction. It is associated with gluten-sensitive enteropathy and increased IgA production by gut lymphoid tissue. We report four cases of immunologically documented DH studied by immunofluorescence technique. Monoclonal antibodies against the IgA subclasses IgA1 and IgA2 were used. IgA1 without IgA2 was found in the cutaneous deposits in each case. The IgA1 had both kappa and lambda light chains in approximately equal quantities. Because normal gut-associated lymphoid tissue produces 70% IgA1 and 30% IgA2, while circulating IgA is primarily IgA1, it could be concluded that the IgA in the skin of DH patients is not produced in the gut. However, the subclass restriction of the IgA produced by pathologic gut-associated lymphoid tissue is unknown. Alternatively, both IgA1 and IgA2 may be produced by the gut, but only IgA1 is involved in the production of cutaneous lesions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082293     DOI: 10.1001/archderm.122.4.418

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  Normal IgA production by peripheral blood lymphocytes in dermatitis herpetiformis and linear IgA dermatosis.

Authors:  F Wojnarowska; S Perl
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Decreased numbers of circulating plasmablasts and differences in IgA1-plasmablast homing to skin in coeliac disease and dermatitis herpetiformis.

Authors:  J M Kantele; E Savilahti; M Westerholm-Ormio; S Pakkanen; H S Arvilommi; T Reunala; A M Kantele
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

3.  Association between levels of IgA antibodies to tissue transglutaminase and gliadin-related nonapeptides in dermatitis herpetiformis.

Authors:  Justyna Gornowicz-Porowska; Monika Bowszyc-Dmochowska; Agnieszka Seraszek-Jaros; Elżbieta Kaczmarek; Marian Dmochowski
Journal:  ScientificWorldJournal       Date:  2012-04-01

4.  Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment.

Authors:  Marcos Vinícius Clarindo; Adriana Tomazzoni Possebon; Emylle Marlene Soligo; Hirofumi Uyeda; Roseli Terezinha Ruaro; Julio Cesar Empinotti
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.